Hubble Therapeutics, LLC

New Filing
CIK: 0002038883·Biotechnology·DELAWARE·Filed: Oct 21, 2024
Total Offering

$11,107,697

Amount Sold

$9,807,697

Investors

17

First Sale

Oct 9, 2024

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Limited Liability Company
Year Incorporated
2020
Non-Accredited Investors
No

Related Persons

NameRole
Jeff Sabados
Related Person
Greg Keenan
Related Person
Sam Goldberger
Related Person

Company

Hubble Therapeutics, LLC

35 SOUTH MAIN STREET

HANOVER, NH, 03755

(617) 780-2375

SEC Filing

0002038883-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Hubble Therapeutics, LLC Form D Filing — $11,107,697 | FilingFlow